Skip to main content
Probi logo

Probi — Investor Relations & Filings

Ticker · PROB ISIN · SE0001280355 LEI · 5493004CJOCT273MU397 ST Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2011-03-31 Annual Report
Country SE Sweden
Listing ST PROB

About Probi

https://www.probi.com/

Probi is a global biotics company specializing in the research, development, and manufacturing of clinically documented probiotic strains. The company provides biotic solutions for dietary supplements and functional foods, targeting specific health needs across various life stages. Its portfolio addresses key areas such as digestive, immune, mental, and metabolic health, alongside specialized formulations for women, children, and healthy aging. Probi's offerings are founded on extensive scientific research and clinical studies to ensure proven efficacy in supporting human health.

Recent filings

Filing Released Lang Actions
Annual Report 2010
Annual Report Classification · 1% confidence The document is titled 'Årsredovisning 2010' (Annual Report 2010) for Probi AB. It contains a comprehensive overview of the company's activities, financial statements (IFRS), management report (VD-ord), board of directors information, and audit report references. It is a full-length annual report covering the fiscal year 2010, not an announcement or a summary. FY 2010
2011-03-31 Swedish
Kallelse till årsstämma i Probi AB (publ)
AGM Information Classification · 1% confidence The document is titled 'Kallelse till årsstämma i Probi AB (publ)' which translates to 'Notice of Annual General Meeting in Probi AB (publ)'. It details the date, time, location, procedures for participation (shareholder registration deadline, proxy submission), and a detailed agenda ('Förslag till dagordning'). The agenda includes items typical for an AGM, such as electing the chairman, approving the annual report, deciding on profit distribution (dividend proposal), electing board members, and approving remuneration guidelines and incentive programs. This content clearly identifies the document as the official notice and materials related to an Annual General Meeting. Therefore, the correct classification is AGM-R.
2011-03-29 Swedish
Probis samarbete med Bringwell/Green Medicine har utvecklats över förväntan
Regulatory Filings Classification · 1% confidence The document is a press release written in Swedish, announcing positive developments regarding the company's probiotic products (ProbiMage and ProbiFrisk) and their market performance, including sales growth and upcoming launches in Finland and Norway. It contains quotes from the CEO, Michael Oredsson, and mentions market research data (GFK). The structure, use of 'PRESSMEDDELANDE' (Press Release), and focus on recent operational and sales achievements strongly suggest this is an announcement of recent business news rather than a formal regulatory filing like a 10-K, an earnings release (ER) which usually contains structured financial tables, or a comprehensive quarterly report (IR). Given the content focuses on business updates and market performance, it fits best as a general announcement. Since there isn't a specific code for a general press release about business operations, and it's not a formal financial statement, the most appropriate fallback category is Regulatory Filings (RNS), which often captures non-standard, material press announcements. However, upon reviewing the definitions, this document is a detailed update on product success and strategy, which often accompanies or precedes an Earnings Release (ER) or Management Discussion (MDA). Since it is a press release detailing operational success and market position rather than just the headline numbers of an ER, and it is not a formal financial report, RNS is the safest general regulatory announcement category. Given the length (3306 chars) and content, it is the announcement itself, not a notice to download a report (ruling out RPA).
2011-03-22 Swedish
Probi inleder återköp av egna aktier
Transaction in Own Shares Classification · 1% confidence The document is a press release written in Swedish, announcing that the Board of Directors of Probi AB has decided to initiate a buyback of its own shares ('återköp av egna aktier'). The text details the maximum number of shares (150,000) and the purpose (to increase shareholder value and flexibility). This action—the company buying back its own stock—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2011-03-07 Swedish
Probi signs distribution agreement with Ta`am Teva Altman in Israel regarding Lp299v™ dietary supplements
Regulatory Filings Classification · 1% confidence The document is titled 'PRESS RELEASE' and announces a specific business event: signing a distribution agreement for a dietary supplement in Israel. It includes details about the agreement, market size, and contact information. It is not a comprehensive financial report (like 10-K or IR), an earnings release (ER), a proxy statement (DEF 14A), or a transcript (CT). Since it is a specific, non-standard business announcement that doesn't fit the other specialized categories (like M&A, Capital Change, Dividend), it falls best under the general regulatory announcement category, RNS, as it explicitly states the information is disclosed in accordance with Swedish Securities Market Act.
2011-02-03 English
Probi tecknar distributionsavtal med Ta`am Teva Altman för kosttillskott baserat på Lp299v™ i Israel
Report Publication Announcement Classification · 1% confidence The document is a press release written primarily in Swedish, announcing a distribution agreement for Probi's probiotic products in Israel with Ta'am Teva Altman. It contains key highlights, quotes, contact information, and boilerplate descriptions of the involved companies (Probi and Ta'am Teva Altman). The structure (PRESS Information, contact details, 'About' sections) strongly indicates a formal announcement intended for immediate public release, rather than a comprehensive regulatory report (like 10-K or IR) or a transcript. Since it is an announcement of a business development/partnership, it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous, time-sensitive corporate announcement, as there is no specific code for 'Business Development Announcement'. The document length (2564 chars) is short, but the content is the core announcement itself, not just a notice that a report is attached, thus ruling out RPA based on the 'Menu vs Meal' rule interpretation for this type of content.
2011-02-03 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.